Hmga2 is dispensable for cutaneous squamous cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Developmental Biology

Background:

• High mobility group AT-hook 2 (Hmga2) is a chromatin-associated factor crucial during development but typically silenced in adult tissues.
• Aberrant Hmga2 expression in adult tissues is linked to various human cancers, with prior studies suggesting its role in epithelial-to-mesenchymal transition (EMT) and cancer progression via gain-of-function mechanisms.
• The necessity of Hmga2 for EMT, tumor formation, and progression remained unclear.

Discussion:

• This study investigated the necessity of Hmga2 in squamous cell carcinoma (SCC) by creating mouse models with Hmga2 deletion.
• The findings indicate that Hmga2 is dispensable for EMT, tumor initiation, and progression in these SCC models.
• Tumors lacking Hmga2 induction developed characteristic cutaneous spindle cell and squamous cell carcinomas, exhibiting typical pathological and molecular features.

Key Insights:

• Hmga2 is not required for the initiation or progression of squamous cell carcinoma in the investigated mouse models.
• Epithelial-to-mesenchymal transition (EMT) processes in SCC development are not dependent on Hmga2.
• The study challenges the assumed necessity of Hmga2 in cancer progression, highlighting its dispensability in specific contexts.

Outlook:

• Further research is needed to elucidate the precise roles of other factors in Hmga2-independent SCC development.
• Investigating compensatory mechanisms in Hmga2-deficient tumors could reveal novel therapeutic targets.
• Understanding the context-dependent functions of Hmga2 in different cancer types is crucial for targeted therapies.